Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has secured a multi-million pound cont...

London, UK, Quanticate, a leading global data-focused clinical research organisation (CRO) has named David Hukin as the company's new Senior Director of Pharmacovigil...

Through negative selection, Cellect's technology identifies mature cells that can be harmful to the recipient and selectively eliminates those cells through apoptosis...